At the forefront of the mental health care revolution
Numinus Wellness empowers people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted psychotherapies. The Numinus Wellness model, from Health Canada-licensed lab to clinical care, is at the forefront of a transformation aimed at curing conditions such as depression, anxiety, trauma, pain and substance abuse. At Numinus, we are leading the integration of psychedelics into mainstream healthcare, and building the foundation for a healthier planet.Download Investor Presentation (PDF)
Numinus is an integrated mental health company creating an ecosystem of health solutions to research, develop, and deliver safe, evidence-based, accessible psychedelic-assisted psychotherapy.
Numinus Bioscience is a Health Canada-licensed lab for psychedelic substance research, developing IP while offering analytics services for revenue generation.
Numinus R&D is developing psychedelic-assisted therapeutic protocols to embed in mainstream healthcare, led by medical leadership with global research and policy reform experience.
Numinus Health supports practitioners in delivering best-in-class treatments by offering centralized, Numinus-owned training, facilities and other operational resources for effective care delivery and healthcare impact.
These solutions position Numinus at the forefront of psychedelics for healing and wellness.
Numinus is led by scientific, medical and business leaders whose expertise spans international healthcare research, policy reform, regulatory affairs, capital markets, technology, and government relations.
This capable leadership manages a team of highly trained research and health care professionals while maintaining a robust network of relationships with advisors, partners, and investors across North America and Europe.
Such synergy allows Numinus to drive financially sustainable development and nimbly navigate this nascent industry.Meet The Team
Our Path Forward
Advocating for access, regulatory change, patient safety and open science.